Pricing

Immunocore Holdings PLC (IMCR)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
CEO: Bahija Jallal
Employees: 320
Web site: immunocore.com
90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, X0, OX14 4RY
01235 5430281
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Immunocore Holdings plc engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. KIMMTRAK is in Phase I/II trials for patients with unresectable or metastatic uveal melanoma. The company's programs for infectious diseases include IMC-I109V, which is in a clinical trial in patients with chronic hepatitis B virus.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available